UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000023397
Receipt No. R000026956
Scientific Title An analysis of permeability of the gastrointestinal epithelium in functional dyspepsia (FD) patients
Date of disclosure of the study information 2016/08/01
Last modified on 2020/01/31 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title An analysis of permeability of the gastrointestinal epithelium in functional dyspepsia (FD) patients
Acronym An analysis of permeability of the gastrointestinal epithelium in FD patients
Scientific Title An analysis of permeability of the gastrointestinal epithelium in functional dyspepsia (FD) patients
Scientific Title:Acronym An analysis of permeability of the gastrointestinal epithelium in FD patients
Region
Japan

Condition
Condition Functional dyspepsia
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluation of mucosal impedance of epithelium of the upper gastrointestinal tract in Functional dyspepsia patients.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Evaluation of whether or not mucosal impedance is related to the functional dyspepsia
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 Tissue Conductance Meter in FD patients
Interventions/Control_2 Tissue Conductance Meter in non-FD patients
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients
1. Patients who are diagnosed functional dyspepsia or who are suspected of functional dyspepsia by Rome III criteria.
2. Patients from whom written informed consent is obtained.
3. Patients who are older than 20 years old.
4. Patients who are taking proton pump inhibitor, H2 antagonist or mucosal protective agent are also included.

non-FD patients
1. Patients who are not diagnosed functional dyspepsia by Rome III criteria.
2. Patients from whom written informed consent is obtained.
3. Patients who are older than 20 years old.
4. Patients who are diagnosed functional dyspepsia are also included even if they have organic disease.
Key exclusion criteria 1. Patients who are judged as contraindication for endoscopy.
2. Patients who are judged as being inappropriate for this study by their medical doctor.
3. Patients from whom written informed consent is not obtained.
4. Patients who have organic diseases after endoscopy and which could cause the upper abdominal symptoms.
Target sample size 130

Research contact person
Name of lead principal investigator
1st name Yoshihiro
Middle name
Last name Ogawa
Organization Kyushu University Graduate School of Medical Sciences
Division name Department of Medicine and Bioregulatory Science
Zip code 8128582
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
TEL 092-642-5286
Email yogawa@intmed3.med.kyushu-u.ac.jp

Public contact
Name of contact person
1st name Eikichi
Middle name
Last name Ihara
Organization Kyushu University Graduate School of Medical Sciences
Division name Department of Medicine and Bioregulatory Science
Zip code 8128582
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
TEL 092-642-5286
Homepage URL
Email eikichi@intmed3.med.kyushu-u.ac.jp

Sponsor
Institute kyushu university
Institute
Department

Funding Source
Organization kyushu university
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization KYUSHU UNIVERSITY Center for Clinical and Translational Research(CCTR)
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, JAPAN
Tel 092-642-5774
Email byskenkyu@jimu.kyushu-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 08 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 58
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 08 Month 02 Day
Date of IRB
2016 Year 07 Month 15 Day
Anticipated trial start date
2016 Year 09 Month 01 Day
Last follow-up date
2019 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2016 Year 07 Month 29 Day
Last modified on
2020 Year 01 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000026956